4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-23-001607
Chief Medical Officer gave up 11,023 shares (to pay taxes)
- Chief Medical Officer acquired 19,690 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | 2023-01-03 | Option exercise | +19,690 | 32,571 | D: show line 1 in the form | ||
| GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | 2023-01-03 | Shares withheld for taxes | −11,023 | $6.11 | $67,351 | 21,548 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | 2023-01-03 | Option exercise · Restricted Stock Units | −19,690 | 0 | D: show line 3 in the form |
Loading xslF345X03/tm232380d3_4seq1.xml…